Phase 3 Aspire study enrollment on track to complete in 2025 Aurora study to evaluate GTX-102 in other Angelman syndrome genotypes and ages expected to initiate later this year NOVATO, Calif., June 27 ...

Q&A with Model N's Michael Grosberg drills deeper into the new US drug pricing directives, including challenges in ...

Novo Nordisk plans to expand access to Wegovy through a collaboration with WeightWatchers, days after ending a partnership with telehealth firm Hims & Hers to sell the weight-loss drug.

Scientists have developed an innovative method to produce and rapidly analyze a vast array of macrocyclic peptides, molecules ...

Gulf Energy Information, a global leader in B2B media, data, and events for the process industries, announced a strategic media partnership with CompareNetworks, a premier media and technology company ...

To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered ...

GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies, has transferred the upstream phase of the manufacturing process for LUMEVOQ, its gene ...